Blackstone
Operates an investment platform that raised a $6.3 billion life-sciences fund to back companies in healthcare and biotechnology.
Overview
Blackstone is an investment manager with a life-sciences strategy focused on deploying capital into healthcare and biotechnology opportunities. The provided funding context centers on its latest life-sciences fund rather than an AI product or operating technology business. The firm raised $6.3 billion in an undisclosed round dated March 30, 2026, for the fund. Its differentiator in this context is the scale of dedicated capital available for life-sciences investments.
Funding History
Blackstone Raises $6.3 Billion for Latest Life-Sciences Fund
Blackstone completed its initial public offering, selling common units at $31 per unit and raising approximately $4.13 billion.
China Investment Corporation agreed to buy a non-voting stake in Blackstone ahead of its public offering for $3 billion.
American International Group acquired a minority stake in Blackstone as part of a strategic relationship, reported as $150 million for roughly 7% of the firm.
Nikko Securities made a strategic minority investment in Blackstone, reported as $100 million for about a 20% stake.
Stephen A. Schwarzman and Peter G. Peterson founded Blackstone with approximately $400,000 of startup capital.
Frequently Asked Questions
- How much has Blackstone raised in total?
- Blackstone has raised a total of $13.7B across 6 funding rounds.
- Who are Blackstone's investors?
- Blackstone's investors include Nikko Securities, American International Group, China Investment Corporation.
- What does Blackstone do?
- Blackstone is an investment manager with a life-sciences strategy focused on deploying capital into healthcare and biotechnology opportunities. The provided funding context centers on its latest life-sciences fund rather than an AI product or operating technology business. The firm raised $6.3 billion in an undisclosed round dated March 30, 2026, for the fund. Its differentiator in this context is the scale of dedicated capital available for life-sciences investments.
- Where is Blackstone headquartered?
- Blackstone is headquartered in New York, United States.
Investors
Related Insights
A comprehensive analysis of Isembard's funding history, investors, competitive position, and growth trajectory in the Deep Tech space.
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
395 AI funding deals worth $337B tracked in 2026. Complete guide to raising pre-seed, seed, Series A/B/C+ for AI startups. Valuations, metrics VCs demand, top investors (Sequoia, a16z, Lightspeed), and how AI funding differs from traditional tech. Includes real deal sizes, timelines, and founder strategies.